Literature DB >> 18643787

Mechanisms of hyperthermia-induced depression of GABAergic synaptic transmission in the immature rat hippocampus.

Lintao Qu1, L Stan Leung.   

Abstract

Clinical observations and experimental studies have shown that hyperthermia can provoke febrile seizures, which are the most common type of pathological brain activity in children. We previously demonstrated that hyperthermia produced a depression of GABAergic neurotransmission in the hippocampus of immature rats in vitro. To investigate the possible mechanisms through which hyperthermia may modulate GABAergic neurotransmission in the hippocampus, whole-cell voltage clamp recordings were performed on CA1 pyramidal neurons in the immature rat brain slices. We found that hyperthermia (38.4-40 degrees C) when compared with baseline temperature of 32 degrees C reduced the frequency of both spontaneous inhibitory post-synaptic currents (sIPSCs) and miniature IPSCs (mIPSCs). Also, hyperthermia decreased the amplitudes of mIPSCs and reduced the mIPSC decay time constants and charge transfer. Non-stationary noise analysis of mIPSCs suggested that the number of open post-synaptic receptors but not single channel conductance was reduced during hyperthermia. Activation of adenylyl cyclase with forskolin prevented, whereas protein kinase A inhibitor N-(2-[p-bromocinnamylamino]ethyl)-5-isoquinolinesulfonamide potentiated, the hyperthermia (40 degrees C)-induced depression of evoked IPSCs (evIPSCs). But protein kinase C activator phorbol 12, 13-dibutyrate (PDBu) did not significantly affect this depression of evIPSCs induced by hyperthermia. Furthermore, hyperthermia-induced depression of evIPSCs was attenuated by 4-aminopyridine, but not by BaCl(2). These results suggest that hyperthermia reduces GABA release from pre-synaptic terminals, in part by blocking the adenylyl cyclase-protein kinase A signaling pathway and activating pre-synaptic 4-aminopyridine-sensitive K(+) channels. Also, the changes in amplitude and decay time constant of the mIPSCs may suggest that hyperthermia also decreases post-synaptic GABA(A) receptor function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18643787     DOI: 10.1111/j.1471-4159.2008.05576.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Reduction of spike generation frequency by cooling in brain slices from rats and from patients with epilepsy.

Authors:  Sadahiro Nomura; Hiroyuki Kida; Yuya Hirayama; Hirochika Imoto; Takao Inoue; Hiroshi Moriyama; Dai Mitsushima; Michiyasu Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-17       Impact factor: 6.200

2.  Early-life febrile seizures worsen adult phenotypes in Scn1a mutants.

Authors:  Stacey B B Dutton; Karoni Dutt; Ligia A Papale; Sandra Helmers; Alan L Goldin; Andrew Escayg
Journal:  Exp Neurol       Date:  2017-04-01       Impact factor: 5.330

3.  Cattle Bile Arisaema Aqueous Extracts Protect Against Febrile Seizures in Rats Through Regulating Neurotransmitters and Suppressing Neuroinflammation.

Authors:  Fa-Zhi Su; Chen-Xi Bai; Yumeng Luo; Wen-Sen Zhang; Na Cui; Yang-Yang Wang; Yan-Ping Sun; Wen-Bo Zhu; Ming-Yang Zhao; Bing-You Yang; Hai-Xue Kuang; Qiu-Hong Wang
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

4.  High temperatures alter physiological properties of pyramidal cells and inhibitory interneurons in hippocampus.

Authors:  Jennifer A Kim; Barry W Connors
Journal:  Front Cell Neurosci       Date:  2012-07-06       Impact factor: 5.505

5.  Fever, Seizures and Encephalopathy: From Bush Fires to Firestorms.

Authors:  Prabhjot Kaur; Suvasini Sharma; Ramesh Konanki; Asuri N Prasad
Journal:  Ann Indian Acad Neurol       Date:  2022-09-09       Impact factor: 1.714

6.  Anticonvulsive effect of paeoniflorin on experimental febrile seizures in immature rats: possible application for febrile seizures in children.

Authors:  Hitomi Hino; Hisaaki Takahashi; Yuka Suzuki; Junya Tanaka; Eiichi Ishii; Mitsumasa Fukuda
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.